CTOs on the Move

bill tobin

www.billtobin.com

 
bill tobin is a Port Chester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million
  • www.billtobin.com
  • 168 Irving Ave Ste 500-f
    Port Chester, NY USA 10573
  • Phone: 914.939.9350

Executives

Name Title Contact Details

Similar Companies

G T S Scientific Inc

G T S Scientific Inc is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Normed

Normed is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Balt

Since it was established in 1977, Balt has worked with interventional physicians to develop devices to treat complex life-threatening neurovascular conditions such as ischemic strokes, aneurysms, and arteriovenous malformations. A pioneer in the neurovascular field, Balt designs, manufactures, and distributes the broadest portfolio of products in the neurovascular space and is focused on expanding its geographic reach.

Biochemical Diagnostics Inc

Biochemical Diagnostics Inc is a Edgewood, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Endologix

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company`s focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Approximately 1.7 million Americans have AAA, and the incidence of the condition increases with age. Endologix is currently marketing the AFX® Endovascular AAA System is available in the U.S., Europe, Latin America and other regions. The Nellix® EndoVascular Aneurysm Sealing System, a novel aneurysm sealing system, is approved for sale in Europe and other markets and for investigational use in the U.S. The Powerlink with IntuiTrak® Delivery System is available in Japan. These technologies are minimally invasive, allowing for greater patient comfort and quicker recovery compared to invasive surgical alternatives. Endologix products are protected by at least 52 U.S. patents with at least 956 allowed claims. Endologix is a publicly-held company trading on NASDAQ: ELGX. The Company`s corporate office is located in Irvine, California.